tally acts on phenotypes and their relationships to the microenvironmental context, not on genotypes. Many different biological mechanisms could influence evolutionary dynamics, including tissue architecture, the genotypephenotype map and accessibility of genotype space, and the constancy of the microenvironment. However, a tumor is composed of proliferating cancer cells, and any expanding clone will naturally carry all heritable genomic changes of the clone to higher frequency in the tumor. This effect is called 'hitchhiking' and is well known in the absence of recombination. Population genetics approaches like the one situation where there is no subclonal selection within a population: all mutations that accrue are passengers and all drivers were already present in the first transformed cell. Neutrality is the null model of molecular evolution 3 , and our analysis showed that for a considerable proportion of tumors it was not possible to reject the null model. One important consequence is that intratumoral heterogeneity is not necessarily a readout of clonal selection, as had been previously argued, but can resemble a purely neutral process.
For clarity, we summarize briefly the biological basis of our analysis. Selection fundamenWilliams et al. reply: Noorbakhsh and Chuang 1 question the resolvability of evolutionary dynamics from cancer sequencing data. In Williams et al. 2 , we showed that the cumulative distribution of subclonal mutations at variant allele frequency f expected in a neutrally evolving cancer is ( )
and found that this model well approximated the frequency distribution in more than 35% of the 900 cancers of 14 different types that we analyzed. Neutral evolution describes the processes may be resolvable. Promising areas for future investigation may include locationdependent selection, deviations from M • N due to cell cycle-independent mutations, and tissue-specific selection such as differences in solid and liquid tumors. The relationship M • 1/f can be derived from assumptions of a homogeneously replicating population with constant mutation rate per cell division (M • N) and neutral evolution: that is, a mutation that arises when the tumor is of size N will obey f • N -1 at the time of measurement. Our model can be interpreted as maintaining the first assumption while replacing the second with f • N -1/k to take selection into account. The described cases for k give the correct sign of the second derivative of M with respect to 1/f for purifying and diversifying selection. Still, the model is a simplification and treats selection as monotonic with N. In reality, selective pressures are likely to be spatially diverse and punctuated, although investigation of these aspects will require more extensive parameterization.
Williams et al. 1 have provided a valuable conceptualization of population dynamics in tumors and have shown that neutrality is possible. However, models with selection can provide similarly good fits to the TCGA data, and TCGA data still yield substantial uncertainties about the true frequency distribution. More refined evolutionary models and further increases in sequencing depth, along with careful statistical modeling of sequencing data 3 , will be important to resolve what balance of selection and neutrality exists in cancer. Interestingly, even aside from the considerations we have raised, Williams et al. 1 already found there to be many cases that did not fit the neutral model, and in some cases the selective closely fit the TCGA data (mean R 2 values were 0.84, 0.88, and 0.73 for k = 1, 0.5, and 2, respectively), but the purifying selection model 1/ f in fact fit the data slightly better. Although our analysis does not clearly show a lack of neutrality, it does indicate that R 2 is not a good measure for distinguishing neutral evolution.
Another consideration is that noise inherent in M(f) curves limits conclusions about neutrality. Assuming that the true allele frequency of a mutation is f true , the observed allele frequency f obs will be a sample from a binomial distribution with mean µ = f true and s.d.
( )
given read depth n (on average, n = 102 in the TCGA samples). In the fitting range 0.12 < f true < 0.24, σ f can take on values as large as 0.04, that is, ~30% of the fitting range. We analyzed the effect of this noise directly by simulating observed M(f) curves according to underlying neutral (k = 1), purifying (k = 0.5), and diversifying (k = 2) selection models. M(f) curves were generated by sampling values of f true from the underlying model and then for each value reporting an f obs generated from the binomial distribution with mean f true and read depth n, where n was drawn from a lognormal fit to the pooled TCGA read depth distribution. Figure 1b shows randomly generated M curves obtained by resimulating this process, suggesting that measurement uncertainty can substantially influence the shape of the observed curve and obscure the underlying evolutionary process. Moreover, we repeatedly simulated M(f) curves for each generating process (k = 0.5, 1, and 2) and tested whether the true generating process could be identified. Mean and s.d. of R 2 values are shown in Table 1 . R 2 values to the true model (diagonal elements) were only marginally better than those to the incorrect models and in all cases these differences were less than the s.d. across replicates, suggesting that R 2 is not a sensitive measure for resolving the evolutionary process. 
we employed exploit genetic hitchhiking of passenger mutations to discern the effects of selection 4 , even when the driver lesion itself is unidentified or immeasurable. Selection leads to the selected clone becoming over-represented in the tumor; importantly, this is the case irrespective of what actually drives a clonal expansion (whether it is a copy number alteration, a single-nucleotide variant (SNV), an epigenetic event, or even a non-cell-autonomous effect). Moreover, because of hitchhiking, any subset of mutations from a tumor should inform on the same clonal structure, whether they are mutations from only diploid regions, coding mutations, or noncoding mutations. We demonstrated this property in our analysis of gastric cancer whole-genome sequencing data (Fig. 2c in the original manuscript 2 ; the same dynamics were recovered irrespective of the type of SNV used in the analysis). Noorbakhsh and Chuang 1 argue that models of clonal selection better explain the available data than neutrality (null model). They suggest that the family of distributions ( )
represents the effect of clonal selection, where κ > 1 corresponds to disruptive (diversifying) selection and κ < 1 corresponds to negative (stabilizing) selection. However, these models are not phenomenological in their derivation and hence do not represent the underlying biology. Furthermore, negative selection is compatible with neutrality 5 , and in the case of positive selection Noorbakhsh and Chuang 1 discuss a special case of selection (disrupting/ diversifying selection) that increases variation, as opposed to positive directional selection that in cancer drives clonal expansions, thus reducing variation 6, 7 . To our knowledge, there is no known analytical solution for the subclonal dynamics of expanding populations under selection, and in fact this is a longstanding open problem in population genetics. Various complications that have hindered a general model of selection include the plethora of potential phenotypic changes that might alter fitness in different ways, the importance of context (including both cell-intrinsic (epistasis) and cell-extrinsic (microenvironment) effects), and the timing of mutation in an expanding population. Although no derivation is provided, the model of Noorbakhsh and Chuang 1 appears to assume multiple very commonly mutated alleles that all experience some selection, suggesting the existence of a large number of driver alterations. The paucity of recurrent driver mutations that can be detected in any given cancer calls into question the realism of this assumption 8 . The alternative model, considered in Williams et al. 2 , is that driver mutations are rare in the genome (and thus infrequently acquired) but exhibit large effects. When a driver mutation is acquired, neutral mutations continue to be acquired within the driver clone and these passengers are carried to higher frequency by clonal expansion of the driver clone. Consequently, the frequency distribution shows a characteristic peak centered at the frequency of the expanding subclone ( Supplementary Fig. 11 in ref. 2)-a distribution that is very different from that predicted by Noorbakhsh and Chuang 1 .
Furthermore, our derivations show that the proposed model of selection of Noorbakhsh and Chuang 1 also describes neutral evolution in a population that is following boundarydriven growth (for example, the growth follows a power law such that the number of cells N at time t is N(t) ~t γ ) and γ is a parameter describing the dimension of the growth. Replacing the exponential growth function with powerlaw growth and following the derivation in Williams et al. 2 yields the cumulative distribution of mutations in the form ( )
and setting γ = 2 leads to M(f) = 1/f 2 . The analysis of Noorbakhsh and Chuang 1 shows that this quadratic model well approximates the data from many cancers. We would suggest that this may be more indicative of the change in tumor size over time than of the evolutionary dynamics of tumor subclones. We wholly agree with the authors' comment that their analysis "does not clearly show a lack of neutrality. "
Noorbakhsh and Chuang 1 also question our use of the R 2 statistic to fit our model to the data. We must agree that R 2 values are not the optimal statistic to fit the 1/f distribution, and in follow-up work we are now developing improved tools. However, we were aware of potential shortcomings of the R 2 value, which is why we used a very high R 2 value of 0.98 as our cutoff, to avoid misclassification and thus overinterpretation of the data. Our analysis as it stands shows that the most parsimonious 'null' model of the evolutionary dynamics is an adequate description of the data. In addition, we note that we provided extensive statistical analysis in our original manuscript to test the robustness of our fitting method and our ability to recover the correct evolutionary dynamics ( Supplementary Figs. 9 and 10 in ref. 2) .
Nevertheless, we agree that our analysis, as for any bioinformatic analysis, relies on the quality of the underlying genomic data.
Noorbakhsh and Chuang 1 discuss the problem of 'noise' in measured variant allele frequency (VAF) in The Cancer Genome Atlas (TCGA) data due to limited sequencing depth. Depth clearly constrains the accuracy of VAF measurement. However, we note that when we looked at an independent data set of gastric cancers 9 , which were whole-genome sequenced at very high depth (100×; representing an exemplar data set), we found that our neutral model fit the data very frequently (60 of 78 cases were consistent with neutral growth). Moreover, we had previously computationally investigated the effect of limited sequencing depth on the ability of our model to correctly recover neutral dynamics and observed asymptotic improvements in the fit as depth increased, which were essentially saturated at depths greater than 75× ( Supplementary Fig. 10 of ref. 2). Hence, sequencing depth and VAF determination is only a confounding issue in low-depth sequencing. We suggest that, because of the limited sequencing depth in some samples and our choice of a very conservative threshold, it is possible that more cases are adequately explained by neutral evolution than were identified.
We fully acknowledge the need for better, multiregion, and deeper sequencing data, which will inform with higher accuracy on the way in which tumors grow.
Furthermore, we note that slight deviations from neutrality may beg the question of what clinical relevance weak selection effects that do not have the power to significantly change the clonal composition of a tumor have.
In summary, we are glad that our paper is fueling scientific discussion around such an important topic in the interpretation of cancer genomic data, and we also appreciate the suggestions of the authors to potentially investigate other measures of fit for our model other than R 2 . Nevertheless, we maintain that the models of selection they have proposed would require further theoretical understanding before they could become applicable to cancer genomic data. 
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